Autori: Powles Thomas
| Naslov | Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer (Article) |
| Autori | Powles Thomas ... Radulovic Sinisa S ... (broj koautora 23) |
| Info | FUTURE ONCOLOGY, (2022), vol. 18 br. 19, str. 2361-2371 |
| Projekat | Pfizer; Merck |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma (Article) |
| Autori | Powles Thomas ... Radulovic Sinisa S ... (broj koautora 27) |
| Info | NEW ENGLAND JOURNAL OF MEDICINE, (2020), vol. 383 br. 13, str. 1218-1230 |
| Projekat | Pfizer; Merck [Darmstadt, Germany]Merck & Company |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Maintenance avelumab plus best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) chemotherapy in advanced urothelial carcinoma (UC): JAVELIN Bladder 100 phase III interim analysis. (Meeting Abstract) |
| Autori | Powles Thomas ... Radulovic Sinisa S ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 18, Suppl. S, str. - |
| Projekat | Pfizer |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
